CDEK
← All organizations

DexCom, Inc.

For profitWebsite ↗

Also known as: DexCom, Inc.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

May 1, 2012

Last known activity

Sep 2, 2025

Timeline

1990s

  1. Jun 1, 1999

    DexCom, Inc.— Founded

2010s

  1. May 2, 2016

    Nintamed— Acquired

  2. Aug 22, 2018

    TypeZero Technologies— Acquired

Drugs by trial phase (8 distinct, 8 trials)

Phase 4 (4 own, 0 via acquisition)

Phase 3 (2 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Other trials (1 own, 0 via acquisition)

Indications

Studied for

Subsidiaries (2 direct, 2 total across the full acquisition tree)

Recent trials (8)

Details

Founded
San Diego, CA, US Jun 1, 1999
Last known activity
Sep 2, 2025